Effects of grapefruit juice ingestion - Pharmacokinetics and haemodynamics of intravenously and orally administered felodipine in healthy men

European Journal of Clinical Pharmacology

Volumn 52, Issue 2, 1997, Pages 139-145

  Lundahl, J ^a   Regardh C G ^a   Edgar, B ^a   Johnsson, G ^a  

^a Box 300 47 ^*  (Sweden)

Author keywords

Dietary interaction; Felodipine; Flavonoids; grapefruit juice; pharmacodynamics; pharmacokinetics

Indexed keywords

4 (2,3 DICHLOROPHENYL) 2,6 DIMETHYL 3,5 PYRIDINEDICARBOXYLIC ACID ETHYL METHYL ESTER; DRUG METABOLITE; FELODIPINE; WATER;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG METABOLISM; FLUSHING; FOOD DRUG INTERACTION; FRUIT JUICE; GASTROINTESTINAL MUCOSA; GRAPE; HEADACHE; HEMODYNAMICS; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, ORAL; ADULT; BEVERAGES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CITRUS; CROSS-OVER STUDIES; DRUG INTERACTIONS; FELODIPINE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; INJECTIONS, INTRAVENOUS; INTESTINAL ABSORPTION; INTESTINES; LIVER; MALE; TISSUE DISTRIBUTION; WATER;

EID: 0031001463     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050263     Document Type: Article

References (29)

1. Lundahl J, Regårdh CG, Edgar B, Johnsson G (1995) Relationship between time of intake of grapefruit juice and its effects on pharmacokinetics and pharmacodynamics of felodipine in healthy subjects. Eur J Clin Pharmacol 49: 61-67
2. Watkins P, Wrighton S, Schuetz E, Molowa D, Guzelian P (1987) Identification of glucocorticoid-inducible cytochrome P-450 in the intestinal mucosa of rat and man. J Clin Invest 80: 1029-1036
3. Guengerich FP (1989) Characterization of human microsomal cytochrome P-450 enzymes. Ann Rev Pharmacol Toxicol 29: 241-264
4. De Waziers I, Cugnenc PH, Yang CS, Leroux JP, Beaune PH (1990) Cytochrome P450 isoenzymes, epoxide, hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues. J Pharmacol Exp Ther 253: 387-394
5. Kolars JC, Schmiedlin-Ren P, Schuetz JD, Fang C, Watkins PB (1992) Identification of rifampicin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 90: 1871-1878
6. Lown KS, Kolars JC, Thummels KE, Barnett JL, Kunze KL, Wrighton SA, Watkins PB (1994) Interpatient heterogeneity in expression of CYP3A4 and CYP3A5 in small bowel - lack of prediction by the erythromycin breath test. J Pharmacol Exp Ther 22: 947-955
7. Challenor VF, Waller DG, Renwick AG, Gruchy BS, George CF (1987) The trans-hepatic extraction of nifedipine. Br J Clin Pharmacol 24: 473-477
8. Waller DG, Renwick AG, Gruchy BS, George CF (1984) The first-pass metabolism of nifedipine in man. Br J Clin Pharmacol 18: 951-954
9. Wang S-X, Sutfin TA, Bäämhielm C, Regårdh CG (1989) Contribution of the first-pass metabolism of felodipine in the rat. J Pharmacol Exp Ther 250: 632-636
10. Regårdh CG, Edgar B, Olsson R, Kendall M, Collste P, Shansky C (1989) Pharmacokinetics of felodipine in patients with liver disease. Eur J Clin Pharmacol 36: 473-479
11. Van Harten J, Van Brummelen P, Wilson JHP, Lodewijks MTM, Breimer DD (1988) Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration. Eur J Clin Pharmacol 34: 387-394
12. Ahnoff (1984) Determination of felodipine in plasma by capillary gas chromatography with electron capture detection. J Pharm Biomed Analysis 2: 519-526
13. Wu C-Y, Benet L, Herbert M, Gupta S, Rowland M, Gomez D, Wacher V (1996) Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine. Clin Pharmacol Ther 56: 492-497
14. Edgar B, Regårdh CG, Lundborg P, Romare S, Nyberg G, Rönn O (1987) Pharmacokinetic and pharamacodynamic studies of felodipine in healthy subjects after various single. oral and intravenous doses. Biopharma Drug Dispos 8: 235 248
15. Bengtsson-Hasselgren B, Rönn O, Blychert L-O, Edgar B, Raner S (1990) Acute effects of felodipine and nifedipine on hepatic and forearm blood flow in healthy men. Eur J Clin Pharmacol 38: 529-533
16. Harrison's principles of internal medicine. 13th edn. (1994). McGraw-Hill, New york
17. Ducharme MR, Provenzano R, Dehoome-Smith M, Edwards DJ (1993) Trough concentrations of cyclosporine following administration with grapefruit juice. Br J Clin Pharmacol 36: 457-459
18. Proppe D, Hoch O, Visser K, Maclean AJ (1995) Implication for clinical dosage management of steady-state cylosporine a and metabolite pharmacokinetics in renal patients. Abstract of the ASCPT meeting, San Diego, PII-112: 191
19. Yee GC, Stanley DL, Pessa LJ, Costa TD, Beltz SE, Ruiz Lowenthal DT (1995) Effects of grapefruit juice on blood cyclosporine concentration. Lancet 345: 955-956
20. Balogh A, Weber A, Klinger G (1994) Can grapefruit juice influence the bioavailability of ethinylestradiol? Abstract of the 4th Annual Meeting of the German Society of Clinical Pharmacology and Therapy, Hannover, 1993
21. Schubert W, Cullberg G, Edgar B, Hedner T (1994) Inhibition of 17-beta-estradiol by grapefruit juice in ovariectomized women. Maturitas 20: 155-163
22. Benton R, Honig P, Zamani K, Hewett J, Cantilena LR, Woosley RL (1994) Grapefruit juice alters terfenadine pharmacokinetics resulting in prolongation of QTc. Abstract. Clin Pharmacol Ther 55: 146
23. Honig P, Wortham D, Lazarev A, Cantilena LR (1995) Pharmacokinetics and cardiac effects of terfenadine in poor metabolizers receiving terfenadine concomitant grapefruit juice. Abstract of the ASCPT meeting, San Diego. PII-87: 185
24. Fuhr U, Klittich K, Staib H (1993) Inhibitory effect of grapefruit juice and its bitter principal, naringenin. on CYP1A2 dependent metabolism of caffeine in man. Br J Clin Pharmacol 35: 431-436
25. Merkel U, Sigusch H, Hoffmann A (1994) Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers. Eur J Clin Pharmacol 46: 175-177
26. Abernethy D, Greenblatt D, Shader R (1984) Imipramine-cimetidine interaction: Impairment of clearance and enhanced absolute bioavailability. J Pharm Exp Ther 3: 702-705
27. Edgar B, Regårdh CG, Johnsson G, Johansson L, Lundborg P, Löfberg I, Rönn O (1985) Felodipine kinetics in healthy men. Clin Pharmacol Ther 38: 205-211
28. Ducharme M, Warbasse L, Edwards D (1995) Disposition of intravenous and oral cyclosporine after administration with grapefruit juice. Clin Pharm Ther 57: 485-491
29. Hasselgren B, Rönn O, Edgar B, Johansson P, Wall B (1990) Pharmacokinetics and haemodynamics and diuretic natriuretic effects of felodipine administered as an extended-release tablet. Card Drug Ther 4: 1495-1500